Pariente E A, Goudeau A, Dubois F, Degott C, Gluckman E, Devergie A, Brechot C, Schenmetzler C, Bernuau J
Unité de recherches de Physiopathologie hépatique, INSERM U22, Clichy, France.
Dig Dis Sci. 1988 Sep;33(9):1185-91. doi: 10.1007/BF01535798.
A case of hepatitis B reactivation following bone-marrow transplantation for leukemia in a previously healthy HBsAg carrier is reported. A number of changes in HBV serum markers were contemporary to the acute episode. All of them (increase of HBsAg concentration, conversion from anti-HBe to HBeAg, appearance of anti-HBc IgM and of serum HBV-DNA) were suggestive of a "switching-on" of viral replication. Institution of corticosteroid treatment at the onset of the acute phase did not prevent the fatal outcome.
报告了一例既往健康的乙肝表面抗原(HBsAg)携带者在接受白血病骨髓移植后发生乙肝再激活的病例。乙肝血清标志物的一些变化与急性发作同时出现。所有这些变化(HBsAg浓度升高、从抗-HBe转换为HBeAg、抗-HBc IgM和血清HBV-DNA出现)均提示病毒复制“开启”。急性期开始时使用皮质类固醇治疗未能阻止致命结局。